<?xml version="1.0" encoding="ISO-8859-1"?>
<!-- generator="FeedCreator 1.6" -->
<rss version="0.91">
    <channel>
        <title>Open Tag Directory: Mesylate</title>
        <description>The Open Tag Directory provides a &quot;directory style&quot; interface to popular social bookmarking websites.</description>
        <link>http://www.open-tag-directory.org/tags/Mesylate</link>
        <lastBuildDate>Thu, 08 Jan 2009 22:51:43+0100</lastBuildDate>
        <generator>FeedCreator 1.6</generator>
        <item>
            <title>Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and ...</title>
            <link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&amp;db=pubmed&amp;cmd=Retrieve&amp;dopt=abstractplus&amp;list_uids=1365669</link>
            <description>&lt;p&gt;Hydergine study: 
Saletu B, Grunberger J, Linzmayer L, Anderer P. Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.
Psychopharmacology (Berl). 1992;109(1-2):30-40.
PMID: 1365669 [PubMed - indexed for, &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>nicergoline information - smart-drugs.com (1 Citations)</title>
            <link>http://www.smart-drugs.com/product-info/info-nicergoline.htm</link>
            <description>&lt;p&gt;Nicergoline is an ergoloid mesylate derivative that is currently being used in the battle to treat senile dementia. Interestingly it has been found to improve mental agility through enhancing clarity and perception. 
In this instance it is different to t, &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of ...</title>
            <link>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=2086492&amp;query_hl=3&amp;itool=pubmed_DocSum</link>
            <description>&lt;p&gt;Saletu B, Grunberger J, Anderer R.
On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.
Int J Clin Pharmacol Ther Toxicol., &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by ...</title>
            <link>http://www.journalarchive.jst.go.jp/jnlpdf.php?cdjournal=tjem1920&amp;cdvol=162&amp;noissue=3&amp;startpage=225&amp;lang=en&amp;from=jnlabstract</link>
            <description>&lt;p&gt;Nagasawa H, Kogure K, Kawashima K, Ido T, Itoh M, Hatazawa J.
Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography.
Tohoku J Exp Med. 1990 Nov;162(3):225-33.
PMID: 2091324 [PubMed - indexe, &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive ...</title>
            <link>http://www.bloodjournal.org/cgi/content/full/104/9/2655?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=cml+CHILDREN&amp;andorexactfulltext=and&amp;searchid=1136408269305_6062&amp;FIRSTINDEX=0&amp;sortspec=relevance&amp;resourcetype=1&amp;journalcode=bloodjournal</link>
            <description></description>
        </item>
        <item>
            <title>Nicergoline for dementia and other age associated forms of cognitive impairment (1 Citations)</title>
            <link>http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003159/frame.html</link>
            <description>&lt;p&gt;Fioravanti M, Flicker L. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
Cochrane Database Syst Rev. 2001;(4):CD003159. Review.
PMID: 11687175 , &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>Parkinson's disease - Wikipedia, the free encyclopedia (1 Citations)</title>
            <link>http://en.wikipedia.org/wiki/Parkinson's_disease</link>
            <description>&lt;p&gt;Parkinson&amp;#039;s disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physical movement (akinesia). The primary sympto, &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>erectile dysfunction (1 Citations)</title>
            <link>http://health.yahoo.com/reproductive-medications/erectile-dysfunction/healthwise--ug1808.html;_ylt=Av553BJ99YTYDRFhng7Zh7PdNs4F</link>
            <description>&lt;p&gt;Bromocriptine and cabergoline reduce the body&amp;#039;s amount of prolactin, a hormone produced by the pituitary gland. Excess prolactin makes a woman stop ovulating; in a man, it reduces sperm production, impairs sex drive, and causes impotence (erectile dysfunc, &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>Bromocriptine - Wikipedia, the free encyclopedia (1 Citations)</title>
            <link>http://en.wikipedia.org/wiki/Bromocriptine</link>
            <description>&lt;p&gt;Bromocriptine (brand names include Parlodel), an ergoline derivative, is a dopamine agonist that is used in the treatment of pituitary tumors and Parkinson&amp;#039;s disease., &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
        <item>
            <title>Antidyskinetic (Oral Route, Parenteral Route) - MayoClinic.com (1 Citations)</title>
            <link>http://www.mayoclinic.com/health/drug-information/DR602175</link>
            <description>&lt;p&gt;Antidyskinetics are used to treat Parkinson&amp;#039;s disease, sometimes referred to as &amp;quot;shaking palsy.&amp;quot; By improving muscle control and reducing stiffness, this medicine allows more normal movements of the body as the disease symptoms are reduced. It is also use, &lt;a href='http://delicious.com/tag/mesylate'&gt;delicious.com&lt;/a&gt;&lt;/p&gt;</description>
        </item>
    </channel>
</rss>
